跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Isoptin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Isoptin
Approved
STANDARD
Isoptin
AbbVie Deutschland GmbH & Co. KG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e16ad3972275f636
Company
AbbVie Deutschland GmbH & Co. KG
Type
Standard
Approval Details
Approval Id
e16ad3972275f636
Drug Approval Philippines Name
Isoptin
Product Name
Isoptin
Registration Number
DR-XY23051
Brand Name
Isoptin
Generic Name
Verapamil Hydrochloride
Dosage Form
Film Coated Tablet
Dosage Strength
40mg
Manufacturer
AbbVie Deutschland GmbH & Co. KG
Importer
Abbott Laboratories
Company Detail Path
/organization/abbvie-deutschland-gmbh-and-co-kg
Importer Detail Path
/organization/abbott-laboratories
Issuance Date
27 April 2023
Expiry Date
14 June 2028
Pharmacologic Category
Calcium Channel Blocker
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e16ad3972275f636
Type
Standard
Back to Philippines FDA Approvals